Interestingly, our findings of dysregulated lipoxygenase activity are consistent with previous studies that have reported increased levels of 5-LOX activity in Alzheimer’s disease (AD) [8, 13, 24]. Here, ALOX5 is linked to early-onset autosomal dominant Alzheimer disease.